Quick answer: The benefits of NAD+ come from its job as a coenzyme your cells use to turn food into energy and to run repair and signaling pathways. In humans, whole-blood NAD+ does not clearly rise or fall with age, but the machinery that makes NAD+ is measurably reduced in aged human tissue. Early human research shows that NAD+ precursor supplements (NMN and nicotinamide riboside) can raise blood NAD+ and are generally well tolerated. The biomarker moves; the real-world, felt benefits in people are still modest and developing.
NAD+ (nicotinamide adenine dinucleotide) is one of the most talked-about molecules in the longevity world, and for good reason: almost every cell depends on it. But "NAD+ benefits" gets stretched into promises the science does not support yet. Here is an honest, sourced look at what NAD+ actually does, what changes with age, and what supplementing it can, and cannot, be expected to do. This matters especially for women in midlife, who are often the target of the loudest, least careful marketing in this category.
What is NAD+, and what does it do?
NAD+ is a coenzyme found in every living cell. Its core job is to carry electrons in the redox reactions that convert food into usable energy (ATP), which is why it sits at the center of cellular metabolism. Beyond energy, NAD+ is a required cofactor for enzymes that help cells maintain and repair themselves, including the poly(ADP-ribose) polymerases (PARPs) involved in DNA repair and the enzyme CD38 involved in cellular signaling. Through these enzymes, NAD+ influences DNA repair, cellular maintenance, and how cells respond to stress.
In other words, NAD+ is not a vitamin you "feel." It is infrastructure. That is the honest frame for its benefits: they flow from its central role in normal cellular function and healthy aging,* not from any single dramatic effect. If you want the deeper mechanism, our explainer on what NAD+ is and how it works → walks through the chemistry step by step.
What are the potential benefits of NAD+?
Because NAD+ is required for so many processes, researchers have studied whether keeping it adequate supports several aspects of cellular health. The honest summary: NAD+ is essential for normal cellular function, and maintaining healthy NAD+ metabolism is biologically reasonable, but most of the dramatic "benefits" you see advertised come from animal studies, not finished human trials.
What the evidence reasonably supports as the roles of NAD+ in the body:
- Cellular energy production. NAD+ is indispensable for converting nutrients into ATP, its most fundamental and well-established role.
- DNA repair and cellular maintenance. NAD+-dependent enzymes such as the PARPs participate in repair and stress-response pathways.
- Cellular signaling and regulation. NAD+ acts as a substrate for enzymes that help regulate how cells respond to stress and aging.
Notice the careful wording. These describe what NAD+ does as a molecule. They are not a promise that a capsule will undo aging, fix fatigue, or treat any condition. That distinction is the whole game in this category.
Does NAD+ decline with age?
The short answer: the popular version of this story is out of date. The premise behind most NAD+ marketing is that your NAD+ runs down as you get older and needs topping up. The human data do not cleanly support that.
A 2026 whole-blood study measured NAD+ across seven separate groups of people and found it did not vary with age (Tretowicz 2026, PMID 42135539). Two recent reviews reached a similar verdict: a clear, consistent age-related drop in humans has been seen in only a small number of studies (Peluso 2021, PMID 35010977; Vinten 2025, PMID 41083806). What did move the number in trials was taking a precursor.
At the same time, in aged human muscle the machinery that makes NAD+ is measurably reduced (Migliavacca 2019, PMID 31862890). So the useful question is not whether you are running a fixed deficit, but whether you are giving your body what it uses to keep making NAD+.
Biomarker vs. outcome: read this before you buy anything
What the biomarker does: In randomized human trials, NAD+ precursors reliably raise blood NAD+. NMN raised whole-blood NAD+ at doses from 250 mg to 900 mg per day, including at the 500 mg dose (PMID 37641521; PMID 36482258), and nicotinamide riboside raised NAD+ metabolism in healthy adults (PMID 29599478).
What the outcome does: Whether that rise in blood NAD+ reliably changes how you feel or function over years is still being worked out. Clinical effects in trials so far have been limited and inconsistent, and there is no good evidence that intact oral NAD+ itself raises NAD+ (PMID 37971292). A higher number on a lab test is not the same as a benefit you can feel.
Do NAD+ supplements actually raise NAD+, and does it help?
Most "NAD+" supplements are not NAD+ itself. They are precursors the body converts toward NAD+, chiefly nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR). On the first question, raising blood NAD+, the human evidence is fairly consistent:
- A 2018 randomized, placebo-controlled trial found nicotinamide riboside was well tolerated and stimulated NAD+ metabolism in healthy middle-aged and older adults. The authors described the effects on physiological measures as preliminary and warranting further study, not as established benefits (PMID 29599478).
- A 2023 randomized, dose-finding trial in 80 healthy middle-aged adults found NMN raised blood NAD+ and was safe and well tolerated up to 900 mg/day (PMID 36482258). A separate placebo-controlled trial in adults aged 55 to 70 measured the rise directly at the 500 mg dose (PMID 37641521), and a 2026 pooled analysis of 15 trials confirmed the safety and NAD+ response across the studied range (PMID 42514320).
So precursors can move the biomarker. Whether that biomarker change reliably translates into how you feel or function over years is exactly where the evidence is still developing. Human trials so far have shown limited and inconsistent clinical effects. A skeptic's reading is the correct reading here. If raising NAD+ is your goal, the precursor route is the one with the human data behind it, which is why our NMN 500 → is the best-studied starting point.
NAD+ vs. its precursors: how the forms compare
| Form | What it is | Typical use | Human evidence on raising blood NAD+ |
|---|---|---|---|
| NAD+ (direct) | The coenzyme itself | Oral capsules; IV in clinics | Oral NAD+ has not been shown in good human trials to raise blood NAD+ on its own (PMID 37971292). The trials that measured a rise concentrated on the precursor route, which is why NMN 500 is the best-studied starting point and why CELLSHE NAD+ is built as a three-active formula, not a delivery claim. |
| NMN | A direct NAD+ precursor | 250-900 mg/day in trials | Raised blood NAD+ in randomized trials; generally well tolerated |
| NR | A precursor vitamin (a form of B3) | 250-1,000 mg/day in trials | Raised NAD+ metabolism in randomized trials; generally well tolerated |
| Niacin / nicotinamide | Classic B3 vitamins, also precursors | Established nutrient doses | Raise NAD+ but niacin can cause flushing at higher doses |
If you are weighing the coenzyme itself against a precursor, our NMN vs NAD+ explainer → clears up the difference; and if you are deciding between the two most popular precursors, our NMN vs NR comparison → breaks down the differences in detail.
How to evaluate an NAD+ or precursor supplement
The category is noisy and quality varies widely. A practical checklist:
- Disclosed form and dose. Know whether you are buying NAD+, NMN, or NR, and the exact milligrams per serving, not a hidden "proprietary blend."
- Third-party testing with a COA. Independent lab verification of identity and purity is the single best trust signal. CELLSHE's Certificate of Analysis is available on the product page or on request.
- Sensible, studied doses. Be wary of mega-doses marketed as "what experts take." More is not automatically better, and the human dose-response is still being mapped.
- Honest claims. If a label promises to undo aging, cure fatigue, or promises a sure result, that is a red flag, not a feature.
- GMP manufacturing and a transparent label. Basic quality hygiene you should expect from any premium brand.
For a fuller buyer's walkthrough, see our guide to NAD+ supplements: what actually works →.
What we know, and what we do not
What we know: NAD+ is essential for cellular energy and for the enzymes involved in repair and signaling. In humans, whole-blood NAD+ does not clearly track with age, while the capacity to make NAD+ is reduced in aged tissue. Precursor supplements (NMN, NR) can raise blood NAD+ and have been well tolerated in short and medium-length trials.
What we do not know: Whether raising blood NAD+ reliably improves how people age, feel, or function over the long term; the optimal form, dose, and timing; and how much NAD+ availability really matters across different human tissues. The longest, largest, definitive trials simply have not been done yet.
What NAD+ will not do
To keep this honest: NAD+, as a molecule or a supplement, is not a fountain of youth and not a medicine. It will not replace sleep, movement, and nutrition, and it comes with no promise of a fixed or overnight result. It is not a substitute for medical care. Anyone selling it that way is selling a story, not the science. A supplement is, at most, one small, consistent input into an already-healthy routine.*
Where CELLSHE fits
CELLSHE makes a clean, transparent NAD+ → ($59, or $49 monthly) formula for people who want an evidence-informed, anti-hype option as part of a daily routine. Our NAD+ pairs 500 mg NAD+ with 250 mg quercetin and 150 mg resveratrol, taking the coenzyme-plus-cofactors route rather than a precursor alone.* We do not claim the capsule raises your NAD+, because the honest evidence does not support that for oral NAD+ (PMID 37971292).
What the polyphenols bring is antioxidant support* at the ingredient level. Resveratrol has pooled human evidence for antioxidant activity: one meta-analysis found it raised glutathione peroxidase, while a companion analysis found no clear change in superoxide dismutase, so the picture is real but mixed (PMID 31738139; PMID 31628212). In postmenopausal women, resveratrol with vitamin C lowered a marker of oxidative stress (PMID 39519608). Quercetin, the other polyphenol in the formula, has been studied for its effect on inflammation markers such as C-reactive protein, with the clearest effects at doses at or above 500 mg (PMID 28537580; PMID 31213101). Our formula uses 250 mg, so we describe this as ingredient-level context, not a promised result from this dose.
The point is transparency, not miracles. We promise a premium, honestly-labeled product, third-party tested with a Certificate of Analysis available on the product page or on request, and the context to decide for yourself. Not sure where to begin? The free Cellular Age Check → is a 2-minute starting point. If you would rather see how the pieces work together, our longevity stack explainer → lays out the full picture.
Frequently asked questions
What is NAD+ used for in the body?
NAD+ is a coenzyme used to convert food into cellular energy (ATP) and to power enzymes involved in DNA repair, cellular maintenance, and signaling. It supports normal cellular function and healthy aging.*
What are the main benefits of NAD+?
Its benefits stem from its central role in cellular energy: supporting energy production and the enzymes that help cells repair and regulate themselves.* These are roles of the molecule, not promised outcomes from a supplement.
Do NAD+ supplements have side effects?
In trials, NMN and NR precursors have generally been well tolerated, with no serious safety issues reported at the doses studied; niacin can cause flushing at higher doses. Long-term safety data are still limited, so talk to your clinician, especially if you're pregnant, nursing, or taking medication.
Does NAD+ really decline with age?
In humans, whole-blood NAD+ does not clearly change with age, and a consistent decline has been reported in only a small number of studies. What is clearer is that the capacity to make NAD+ is reduced in aged tissue. It is a more nuanced picture than most marketing implies.
Is it better to take NAD+ directly or a precursor like NMN or NR?
The human trials that measured a rise in blood NAD+ concentrated on the precursor route (NMN and NR); there is no good evidence that intact oral NAD+ raises NAD+ on its own. That is why NMN 500 is the best-studied starting point, and why CELLSHE NAD+ is built as a three-active formula with polyphenols rather than a delivery claim.
References
- Covarrubias AJ, Perrone R, Grozio A, Verdin E. (2021). NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology 22:119-141. PMID: 33353981. pubmed.ncbi.nlm.nih.gov/33353981
- Peluso A, Damgaard MV, Mori MAS, Treebak JT. (2021). Age-Dependent Decline of NAD+, Universal Truth or Confounded Consensus? Nutrients 14(1):101. PMID: 35010977. pubmed.ncbi.nlm.nih.gov/35010977
- Martens CR, et al. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications 9:1286. PMID: 29599478. pubmed.ncbi.nlm.nih.gov/29599478
- Yi L, et al. (2023). The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, dose-dependent clinical trial. GeroScience 45(1):29-43. PMID: 36482258. pubmed.ncbi.nlm.nih.gov/36482258
- Vinten KT, et al. (2025). NAD+ precursor supplementation in human ageing: clinical evidence and challenges. Nature Metabolism. PMID: 41083806. pubmed.ncbi.nlm.nih.gov/41083806
- Tretowicz MM, et al. (2026). Human whole-blood NAD+ levels do not vary with age or lifestyle interventions. Nature Metabolism. PMID: 42135539. pubmed.ncbi.nlm.nih.gov/42135539
- Migliavacca E, et al. (2019). Mitochondrial oxidative capacity and NAD+ biosynthesis are reduced in human sarcopenia across ethnicities. Nature Communications 10:5808. PMID: 31862890. pubmed.ncbi.nlm.nih.gov/31862890
- Wang P, et al. (2023). Fingerstick blood assay maps real-world NAD+ disparity across gender and age (includes a 500 mg NMN placebo-controlled trial). Aging Cell. PMID: 37641521. pubmed.ncbi.nlm.nih.gov/37641521
- Yang W, et al. (2026). Safety and metabolism-related outcomes of oral nicotinamide mononucleotide supplementation: a systematic review and meta-analysis. Nutrients. PMID: 42514320. pubmed.ncbi.nlm.nih.gov/42514320
- Gindri IM, et al. (2024). Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review. American Journal of Physiology-Endocrinology and Metabolism. PMID: 37971292. pubmed.ncbi.nlm.nih.gov/37971292
- Omidian M, et al. (2020). The Effects of Resveratrol on Oxidative Stress Markers: A Systematic Review and Meta-Analysis. Endocrine, Metabolic & Immune Disorders Drug Targets. PMID: 31738139. pubmed.ncbi.nlm.nih.gov/31738139
- Koushki M, et al. (2020). Therapeutic effect of resveratrol supplementation on oxidative stress: a systematic review and meta-analysis. Postgraduate Medical Journal. PMID: 31628212. pubmed.ncbi.nlm.nih.gov/31628212
- Montoya-Estrada A, et al. (2024). The Administration of Resveratrol and Vitamin C Reduces Oxidative Stress in Postmenopausal Women. Nutrients. PMID: 39519608. pubmed.ncbi.nlm.nih.gov/39519608
- Mohammadi-Sartang M, et al. (2017). Effects of supplementation with quercetin on plasma C-reactive protein concentrations: a systematic review and meta-analysis. European Journal of Clinical Nutrition. PMID: 28537580. pubmed.ncbi.nlm.nih.gov/28537580
- Ou Q, et al. (2020). Impact of quercetin on systemic levels of inflammation: a meta-analysis of randomised controlled human trials. International Journal of Food Sciences and Nutrition. PMID: 31213101. pubmed.ncbi.nlm.nih.gov/31213101
